BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 23516360)

  • 21. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
    Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N
    Front Immunol; 2021; 12():643189. PubMed ID: 34475868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
    Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.
    Pulido I; Machmach K; Romero-Sánchez MC; Genebat M; Mendez-Lagares G; Ruiz-Mateos E; Leal M
    J Infect; 2012 Apr; 64(4):417-23. PubMed ID: 22227467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
    Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
    mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.
    Ruiz L; Martinez-Picado J; Romeu J; Paredes R; Zayat MK; Marfil S; Negredo E; Sirera G; Tural C; Clotet B
    AIDS; 2000 Mar; 14(4):397-403. PubMed ID: 10770542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
    Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
    mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Treatment Controllers: Role in HIV "Cure" Research.
    Cockerham LR; Hatano H; Deeks SG
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):1-9. PubMed ID: 26781112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
    Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttreatment controllers: what do they tell us?
    Rouzioux C; Hocqueloux L; Sáez-Cirión A
    Curr Opin HIV AIDS; 2015 Jan; 10(1):29-34. PubMed ID: 25402707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
    Chéret A; Bacchus-Souffan C; Avettand-Fenoël V; Mélard A; Nembot G; Blanc C; Samri A; Sáez-Cirión A; Hocqueloux L; Lascoux-Combe C; Allavena C; Goujard C; Valantin MA; Leplatois A; Meyer L; Rouzioux C; Autran B;
    J Antimicrob Chemother; 2015 Jul; 70(7):2108-20. PubMed ID: 25900157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent trends in early stage response to combination antiretroviral therapy in Australia.
    McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
    Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
    Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
    PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial.
    Goujard C; Emilie D; Roussillon C; Godot V; Rouzioux C; Venet A; Colin C; Pialoux G; Girard PM; Boilet V; Chaix ML; Galanaud P; Chene G;
    AIDS; 2012 Sep; 26(15):1895-905. PubMed ID: 22842994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.